Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single-center analysis in Japan.
Motohiro FujiwaraTakeshi YuasaTetsuya UrasakiYoshinobu KomaiRyo FujiwaraNoboru NumaoShinya YamamotoJunji YonesePublished in: Cancer reports (Hoboken, N.J.) (2021)
We studied the effectiveness and safety profile of pembrolizumab therapy in Japanese UC patients. We believe that the data presented here will be useful for clinical physicians.
Keyphrases
- end stage renal disease
- ejection fraction
- squamous cell carcinoma
- small cell lung cancer
- newly diagnosed
- chronic kidney disease
- primary care
- advanced non small cell lung cancer
- high grade
- prognostic factors
- electronic health record
- machine learning
- big data
- patient reported outcomes
- bone marrow
- mesenchymal stem cells
- epidermal growth factor receptor
- replacement therapy
- artificial intelligence
- smoking cessation